Usefulness of &omega;-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: A double-blind, randomized, placebo-controlled study

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 45

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

621

HTML

6627

Figures (1-1)

409

Tables (1-1)

416

Sum=8073

Dec 7, 2005 (publication date) through Nov 3, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Dec 7, 2005; 11(45): 7118-7121
Published online Dec 7, 2005. doi: 10.3748/wjg.v11.i45.7118

Table 1 Characteristics of patients at the beginning of the study

Citation: Romano C, Cucchiara S, Barabino A, Annese V, Sferlazzas C, Diseases SISGOPIB. Usefulness of ω-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: A double-blind, randomized, placebo-controlled study. World J Gastroenterol 2005; 11(45): 7118-7121
URL: https://www.wjgnet.com/1007-9327/full/v11/i45/7118.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i45.7118